Startup City

Canary Speech
Customized and Non-Invasive Approach in Providing Healthcare Solutions

Henry O'Connell, CEO, Canary SpeechHenry O'Connell, CEO
Speech patterns, their complexity and vocabulary, play a pivotal role in determining behavioral nature of people. However, something truly interesting happens when one applies the use of speech and language to the diagnosis of health conditions. The patterns become more relevant and imperative, crucial to the understanding of underlying biomarkers that can measure a person’s state of well being. Alas, the availability—or lack thereof—of patient data pertaining to specific diseases, presents a challenge to such revelations. This in turn, makes it difficult to find the right clinical partners who can verify the available information and validate the models based on that data. Canary Speech with its guided ML and AI, has redefined the potential of speech and language to select biomarkers that can be used to perform analysis of specific diseases. The company is going beyond historical methods of performing word-based analysis, with its own unique approach. By being specific and sensitive analysis of speech patterns, Canary Speech can track the diseases’ progress and map the efficacy of the therapeutics used. As Henry O’Connell, the CEO of Canary Speech rightly puts it, “It is critical to be able to apply technology in areas for both clinical treatment and new drug discovery. We want to be able to tell how affective therapeutics is in the treatment of any disease. What we did at Canary Speech was to pursue a more detailed understanding what was being communicated in non-word elements.
Our novel approach towards speech and language has been awarded with issued U.S patents and international approvals.”

Canary Speech deploys its solutions via three technologies. The first being the Canary Engine which helps to identify the specific diseases. It also acts as the portal to receive and process data and match it with the existing biomarkers to understand the specific predicament of the users. The company’s other focus is on collecting adequate data pertaining to different diseases, which enables it to create mathematical models or algorithms that are used to recognize the diseases and its impact on patients’ lifestyle and their cognitive functions. These models are integrated easily into a smart application that can be accessed via controlled passwords, across a wide range of devices. Once a user has entered this interface, they go through a series of questions and from their answers, the application helps evaluate the audio, while considering the specific disease in question. After this analysis, a score is provided that informs them of the severity of the disease.

Canary Speech also provides a software platform that enables them to participate in pharmaceutical and clinical studies. The platform allows clinicians to capture and engage data in a seamless manner, following the terms of HIPAA compliance. It can further be used to build tool sets, based on coordinated research on language and speech. But what makes Canary Speech ever more unique is its specific and sensitive approach to analysing data both from the clinical environment as well from home. This easy accessibility from any location provides visibility into real-time data and enables a more accurate evaluation. Its offerings also include quality control and quality assurance tools that allow users to carry out personal evaluations on a regular basis. The information provided by the clients is transferred to the appropriate clinic staff before the patients arrive for consultation. The platform is non-invasive as well, allowing users to provide information across the most convenient means of communication. The offering being completely digitized makes it even more efficacious and hassle-free. Canary Speech has been awarded patents for its methodology, approach and technology. Combine that with a wide range of applications targeting depression, stress, anxiety, tiredness, concussion, Alzheimer’s, Parkinson’s, and others, Canary Speech is successfully bridging the gap between technology and healthcare and providing faster means of evaluating patient details via audio and determining the correct treatment for them. The time saved to analyse a person’s condition through its novel platform has truly made its solution affordable and aims to expand into improving clinical trials and new drug discoveries.

Canary Speech News

Canary Speech Accelerates AI Speech Analysis Technology with Microsoft Cloud for Healthcare Integration

Digital vocal biomarker innovator integrates clinical-grade technology providing real-time speech analysis on Microsoft Cloud for Healthcare.

PROVO - Canary Speech, Inc. announced today that it will apply the power of artificial intelligence (AI) voice analysis technology to address a variety of mental health challenges and enable early intervention, reduce healthcare costs, and scale remote patient monitoring (RPM) solutions. As part of the collaboration, Canary Speech has become a Microsoft Cloud for Healthcare co-sell partner and will use Microsoft Azure as its cloud solution to extend its robust machine learning (ML) speech models to new customers.

The API-first platform is designed to integrate with existing solutions to enhance a users' experience and improve clinical outcomes. Partners can also configure the Canary Speech app to capture additional data points in addition to the voice recording / analysis. One way Microsoft customers can easily access and scale Canary AI vocal insights is through its integration with Microsoft Teams .

"Canary Speech continues to pioneer the path in creating, validating and commercializing speech-as-a-biomarker in a way that is transformative for patients and clinicians," said Henry O'Connell, co-founder and CEO of Canary Speech, of the newly formed collaboration. "We believe that Microsoft's world-class cloud infrastructure and global reach and scale, combined with our ML and AI expertise, creates truly next generation solutions."

Microsoft Cloud for Healthcare provides trusted and integrated capabilities, connectors, workflows, data and AI models that make it easier for organizations to create personalized patient and member experiences, accelerate data driven decision-making, empower health teams with connected and secure productivity tools, and adopts data standards that are important to healthcare.

"AI is helping to empower healthcare providers by automating tasks, transforming unstructured forms of data into structured formats, gleaning patient insights, and supporting clinicians in delivering personalized patient care," said David Rhew, M.D., Global Chief Medical Officer and Vice President of Healthcare, Microsoft. "Canary Speech is applying AI to enable voice to serve as a biometric, which could potentially aid in the screening and monitoring of medical conditions. We are pleased to work with Canary to help transform care through AI technology that can make a positive impact on the industry and patient outcomes."

Canary's patented technology offers a novel method for capturing and analyzing critical data. This approach involves using AI and machine learning techniques to examine speech features known as "biomarkers." By replacing subjective behavioral health measurements with a more standardized and objective approach, this technology can comprehensively measure an array of data points.

Canary Speech Secures $13M for AI-Powered Vocal Biomarkers

–Canary Speech, Inc. (Canary), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $13M Series A funding round.

– The round was led by Cortes Capital, LLC (Love’s Private Equity), with participation from Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health.

Canary’s Cutting-Edge Technology

Canary Speech leverages vocal analysis to identify early signs of mental health and neurological conditions. Their patented technology analyzes speech data within seconds, detecting subtle vocal changes that may precede typical clinical symptoms of conditions like anxiety, depression, and dementia. This enables proactive intervention and improved patient outcomes.

Applications Transforming Patient Care

Canary’s API-first approach offers a versatile platform with multiple applications within healthcare:

• Contact centers: Canary helps assess caller well-being during interactions.

• Ambient clinical listening: Canary enhances this technology by providing real-time behavioral and cognitive screening, offering crucial data to providers.

• Remote patient monitoring: Allows for ongoing monitoring and early detection of potential healthcare issues.

• Annual wellness checks: Canary’s technology can be integrated into routine checkups for a more comprehensive assessment.

Beyond Patient Care: Supporting Healthcare Professionals

Canary’s technology extends its reach to support healthcare professionals facing burnout. By analyzing physicians’ voices during patient interactions, Canary can identify potential burnout symptoms, allowing healthcare systems to proactively support their staff.

Funding Fuels Growth and Innovation

This funding round empowers Canary to:

• Expand its team: Recruit top talent to accelerate growth driven by AI advancements and healthcare’s demand for advanced tools.

• Scale its cloud-based platform: Canary leverages a vast partnership network to rapidly scale its data processing capabilities, serving a wider range of healthcare applications.

“There are technologies that truly disrupt the way healthcare is administered, and Canary is committed to pioneering vocal biomarkers and ambient listening for the betterment of healthcare,” said Henry O’Connell, co-founder and CEO of Canary Speech.

Share this Article:
Top 15 NLP Startups - 2019

Company
Canary Speech

Management
Henry O'Connell, CEO

Description
At its core, Canary Speech is a speech and language company that specializes in the area of identifying disease and human condition through speech. We use a variety of Machine Learning technologies to solve problems at the intersection of healthcare and technology. Canary Speech is focusing on opportunities of critical importance. We have successfully completed FDA clinical trials and IRB studies, while providing HIPAA compliant tools, in Alzheimer’s disease, Parkinson’s and depression related to suicide prevention and the treatment of PTSD